Adjustment of Antimicrobial Regimen in Critically III Patients Undergoing Continuous Renal Replacement Therapy

  • D. Kuang
  • C. Ronco
Conference paper


Infection is a common problem in the intensive care unit (ICU). Severe sepsis and septic shock are conditions at the end of the spectrum of human response to infection. Acute renal failure is increasingly seen as part of the multiple organ dysfunction syndrome, which is the most frequent cause of death in patients admitted to the ICU. However, severe sepsis and septic shock are the primary causes of the multiple organ dysfunction syndrome. In the past decades, continuous renal replacement therapy (CRRT) has been widely employed as an extracorporeal blood purification method in the management of septic patients with or without acute renal failure in the ICU, because it offers several advantages over conventional intermitant hemodialysis and peritoneal dialysis [1].


Acute Renal Failure Continuous Renal Replacement Therapy Multiple Organ Dysfunction Syndrome Drug Clearance Drug Removal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kellum JA, Bellomo R, Ronco C, Mehta R, Clark W, Levin NW (2005) The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs 28:441–444PubMedGoogle Scholar
  2. 2.
    Roberts JA, Lipman J (2006) Antinacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 45:755–773PubMedCrossRefGoogle Scholar
  3. 3.
    Pinder M, Bellomo R, Lipman J (2002) Pharmarcological principles of antibiotic prescription in the criticallly ill. Anaesth Intensive Care 30:134–144PubMedGoogle Scholar
  4. 4.
    Nicolau DP (2003) Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling. J Infect Chemother 9:292–296PubMedCrossRefGoogle Scholar
  5. 5.
    Keller F, Giehl M, Frankewitsch T, Zellner D (1995) Pharmacokinetics and drug dosage adjustment to renal impairment. Nephrol Dial Transplant 10:1516–1520PubMedGoogle Scholar
  6. 6.
    Sweetman SC (2004) Martindale: The Complete Drug Reference. Pharmaceutical Press, LondonGoogle Scholar
  7. 7.
    Aronoff GR, Berns JS, Brier ME, et al (1999) Drug Prescribing in Renal Failure: Dosing Guidelines for Adults, 4th Ed. American College of Physicians, PhiladelphiaGoogle Scholar
  8. 8.
    Ashley C, Currie A The Renal Drug Handbook, 2nd Ed. Radcliffe Medical Press, OxfordGoogle Scholar
  9. 9.
    Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P (1995) Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 21:612–620PubMedCrossRefGoogle Scholar
  10. 10.
    Bugge JF (2001) Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929–934PubMedCrossRefGoogle Scholar
  11. 11.
    Reetze-Bonorden P, Bohler J, Keller E (1993) Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 24:162–179CrossRefGoogle Scholar
  12. 12.
    Vos MC, Vincent HH (1991) Continuous arteriovenous hemodiafiltration: Predicting the clearance of drugs. Contrib Nephrol 93:143–145PubMedGoogle Scholar
  13. 13.
    Vincent HH, Vos MC, Akcahuseyin E, Goessons WH, van Duyl WA, Schalekamp MA (1993) Drug clearance by continuous haemodiafiltration (CAVHD). Analysis of sieving coefficients and mass transfer coefficients of diffusion. Blood Purif 11:99–107PubMedGoogle Scholar
  14. 14.
    Kroh UF, Holl TJ, Steinhausser W (1996) Management of drug dosing in continuous renal replacement therapy. Semin Dial 9:161–165CrossRefGoogle Scholar
  15. 15.
    Bohler J, Donauer J, Keller F (1999) Pharmacokinetic principle during continuous renal replacement therapy: drugs and dosage. Kidney Int Suppl 72:s24–s28PubMedGoogle Scholar
  16. 16.
    Mueller BA, Pasko DA, Sowinski KM (2003) Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 27:808–814PubMedCrossRefGoogle Scholar
  17. 17.
    Kroh UF (1995) Drug administration in critically ill patients with acute renal failure. New Horiz 3:748–759PubMedGoogle Scholar
  18. 18.
    Trotman RL, Williamson JC, Shoemaker DM, Salzer WL (2005) Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin Infect Dis 41:1159–1166PubMedCrossRefGoogle Scholar
  19. 19.
    Scheetz MH, Scarsi KK, Ghossein C, Hurt KW, Zembower TR, Postelnick MJ (2006) Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information. Clin Infect Dis 42:436–437PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • D. Kuang
    • 1
  • C. Ronco
    • 1
  1. 1.Department of Nephrology, Dialysis, and TransplantationSan Bortolo HospitalVicenzaItaly

Personalised recommendations